Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis.
Tailleux
Anne
A
Unité de Recherche INSERM 545, Département d'Athérosclérose, Institut Pasteur de Lille, France.
Torpier
Gérard
G
Mezdour
Hafid
H
Fruchart
Jean-Charles
JC
Staels
Bart
B
Fiévet
Catherine
C
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy / Q000378:metabolism*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D015507:Drugs, Investigational / Q000494:pharmacology*; D006949:Hyperlipidemias / Q000188:drug therapy / Q000378:metabolism*; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D008024:Ligands; D051379:Mice; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000378:metabolism*; D014157:Transcription Factors / Q000819:agonists / Q000378:metabolism*
D015507:Drugs, Investigational; D000960:Hypolipidemic Agents; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors